DAIC

FEBRUARY 21, 2024

Image courtesy of Henry Ford Health milla1cf Wed, 02/21/2024 - 19:07 February 21, 2024 — An 80-year-old woman from Frankenmuth, Michigan is the first Henry Ford Health structural heart disease patient—and the first ever in Michigan—to receive a new transcatheter heart valve device for treating severe tricuspid regurgitation.

Heart Failure 105

Heart Failure Open-Heart Surgery Tricuspid Heart Disease 105

DAIC

JUNE 21, 2024

The EVOQUE tricuspid valve replacement system is a device designed to treat patients with severe leaking of the tricuspid valve, known as tricuspid regurgitation, without open heart surgery.

Tricuspid 105

Tricuspid Quality of Life Open-Heart Surgery Interventional Cardiology 105

DAIC

MARCH 12, 2024

milla1cf Tue, 03/12/2024 - 16:48 March 12, 2024 — Medtronic plc , a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut Low Risk Trial. mmHg SAVR; p "The Evolut TAVR System continues to demonstrate positive clinical outcomes compared to SAVR.

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

DAIC

JANUARY 24, 2024

Barr’s death at 39 from sudden cardiac arrest was caused by mitral valve prolapse—a heart valve defect that can affect the heart’s ability to pump blood. In the past, heart surgeons corrected a faulty mitral valve by replacing it with an artificial one during open-heart surgery.

Bicuspid/Mitral 105

Bicuspid/Mitral Research Heart Valves Cardiac Arrest 105